• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项比较奥替溴铵与高纤维饮食治疗肠易激综合征的随机临床研究。

Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome.

作者信息

Villagrasa M, Boix J, Humbert P, Quer J C

机构信息

Gastroenterology Unit, Germans Trias i Pujol Hospital Badalona, Barcelona, Spain.

出版信息

Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):67-70.

PMID:1661630
Abstract

We studied 114 patients affected by irritable bowel syndrome (IBS) (group A = 53 patients, group B = 61). Group A received diet with high content of roughage (20 g of fibers) and 10 g of bran, group B received otilonium bromide (OB) 40mg tid and normal diet (10-15 g of fibers). Abdominal pain, abdominal distension, bowel movements were evaluated before treatment (T0) at the end (T24) and after 12 months (T12). In group B otilonium bromide induced a significant improvement (p less than 0.01) of abdominal pain and distension when comparing T0 with T24. In group A diet produced an improvement, albeit not significant, of the aforementioned parameters at T24. On the basis of our data OB seems to be more effective than a high-fiber diet in the treatment of IBS.

摘要

我们研究了114例肠易激综合征(IBS)患者(A组 = 53例患者,B组 = 61例)。A组接受高膳食纤维饮食(20克纤维)和10克麸皮,B组接受40毫克奥替溴铵每日三次及正常饮食(10 - 15克纤维)。在治疗前(T0)、结束时(T24)和12个月后(T12)评估腹痛、腹胀和排便情况。在B组中,与T0相比,奥替溴铵在T24时使腹痛和腹胀有显著改善(p小于0.01)。在A组中,饮食在T24时使上述参数有所改善,尽管不显著。根据我们的数据,奥替溴铵在治疗IBS方面似乎比高纤维饮食更有效。

相似文献

1
Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome.一项比较奥替溴铵与高纤维饮食治疗肠易激综合征的随机临床研究。
Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):67-70.
2
Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.奥替溴铵疗效的临床与功能评估:意大利多中心研究
Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):60-3.
3
A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control.奥替溴铵与匹维溴铵作用的比较:临床对照研究
Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):64-6.
4
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.随机临床试验:奥替溴铵可改善肠易激综合征患者腹痛频率、腹胀严重程度和复发时间。
Aliment Pharmacol Ther. 2011 Aug;34(4):432-42. doi: 10.1111/j.1365-2036.2011.04730.x. Epub 2011 Jun 16.
5
Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study.溴化奥昔布宁治疗肠易激综合征:一项临床功能研究。
Hepatogastroenterology. 1992 Oct;39(5):392-5.
6
[Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide].奥替溴铵-地西泮治疗肠易激综合征。与奥替溴铵对照研究
Clin Ter. 1992 Aug;141(8):129-34.
7
A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.美贝维林与高纤维饮食建议及美贝维林加卵叶车前治疗肠易激综合征的比较:一项开放性、前瞻性随机平行组研究。
Br J Clin Pract. 1990 Nov;44(11):461-6.
8
Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.新型抗毒蕈碱药物溴西托品治疗肠易激综合征患者的双盲研究
Clin Ther. 1986;8(3):320-8.
9
[Treatment of irritable bowel syndrome with dicetelium and spasmomen].用双醋苯啶和屈他维林治疗肠易激综合征
Klin Med (Mosk). 2000;78(10):42-6.
10
The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.痉挛抑制剂在治疗肠易激综合征中的应用:以溴氧托铵为例。
Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37.

引用本文的文献

1
Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review.奥替溴铵治疗肠易激综合征的长期疗效及安全性:文献综述
Clin Exp Gastroenterol. 2014 Apr 7;7:75-82. doi: 10.2147/CEG.S46291. eCollection 2014.
2
Benefits from long-term treatment in irritable bowel syndrome.长期治疗肠易激综合征的获益。
Gastroenterol Res Pract. 2012;2012:936960. doi: 10.1155/2012/936960. Epub 2012 Jan 9.
3
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
用于治疗肠易激综合征的容积性泻剂、抗痉挛药和抗抑郁药。
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3.
4
Irritable bowel syndrome.肠易激综合征
Clin Drug Investig. 2007;27(1):15-33. doi: 10.2165/00044011-200727010-00002.
5
Treatment of irritable bowel syndrome: a review of randomised controlled trials.肠易激综合征的治疗:随机对照试验综述
Gut. 2001 Feb;48(2):272-82. doi: 10.1136/gut.48.2.272.